Clune & Associates’s Avantis Emerging Markets Equity ETF AVEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.68M Buy
60,430
+9,585
+19% +$892K 0.87% 30
2026
Q2
$4.91M Sell
50,845
-1,155
-2% -$107K 0.74% 32
2026
Q1
$4.19M Sell
52,000
-6,049
-10% -$502K 0.79% 37
2025
Q4
$4.47M Buy
58,049
+11,034
+23% +$845K 0.97% 32
2025
Q3
$3.53M Buy
47,015
+3,575
+8% +$255K 0.88% 37
2025
Q2
$2.98M Buy
43,440
+1,571
+4% +$98.9K 0.82% 38
2025
Q1
$2.52M Sell
41,869
-140
-0.3% -$8.42K 0.77% 37
2024
Q4
$2.47M Buy
+42,009
New +$2.61M 0.82% 36

Other funds holding AVEM

Clune & Associates's AVEM Position: Q3 2026 in Review

Clune & Associates increased its Avantis Emerging Markets Equity ETF (AVEM) stake by 19% in Q3 2026, buying an estimated $892K and bringing the position to 60,430 shares worth $5.68M. The position accounts for 0.87% of the portfolio, ranked #30.

Clune & Associates first reported a position in AVEM in Q4 2024 and has held it in 8 quarters since. 258 funds tracked by Wall St. Rank hold AVEM as of Q3 2026.

  • Clune & Associates held 60,430 shares of Avantis Emerging Markets Equity ETF worth $5.68M as of Q3 2026.
  • Clune & Associates bought 9,585 Avantis Emerging Markets Equity ETF shares in Q3 2026, an estimated $892K.
  • Avantis Emerging Markets Equity ETF made up 0.87% of Clune & Associates's portfolio in Q3 2026, its #30 holding.
  • Clune & Associates first reported a position in Avantis Emerging Markets Equity ETF in Q4 2024 and has held it in 8 quarters since.
  • 258 funds tracked by Wall St. Rank held Avantis Emerging Markets Equity ETF as of Q3 2026.

Based on Clune & Associates's 13F filing for Q3 2026, filed 8 Oct 2026.